Search Results - "Osteoporosis in women"

基于中医时间医学探讨绝经后骨质疏松症发生与发展.

Alternate Title: Exploration of the occurrence and development of postmenopausal osteoporosis based on time medicine theory of traditional Chinese medicine.

Authors: 汪成杰 徐亚伟 王海涛 et al.

Source: Chinese Journal of Osteoporosis. 2026, Vol. 32 Issue 5, p739-756. 6p.

菟丝子活性成分苦参碱治疗绝经后骨质疏松症: 网络药理学分析及实验验证.

Alternate Title: Network pharmacological analysis and experimental verification of semen cuscutae in treating postmenopausal osteoporosis.

Authors: 徐 晟 张稳稳 张薇薇 et al.

Source: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 4/18/2026, Vol. 30 Issue 11, p2702-2711. 10p.

Comprehensive profiling of gut microbiota in postmenopausal osteoporosis.

Authors: ERTÜRK ÇELİK, Gülsemin YILDIZ, Sedat AKSOY BEKTAŞ, Münevver et al.

Source: Turkish Journal of Medical Sciences. 2026, Vol. 56 Issue 2, p531-540. 10p.

从营卫理论探讨绝经后骨质疏松症.

Alternate Title: Explore postmenopausal osteoporosis from the perspective of Ying-Wei theory.

Authors: 李钰祎 熊伟 朱家钰 et al.

Source: Chinese Journal of Osteoporosis. 2026, Vol. 32 Issue 2, p239-244. 6p.

中药复方治疗绝经后骨质疏松症中医辨证思路.

Alternate Title: Research on TCM syndrome differentiation mechanism of Chinese herbal compound in treating postmenopausal osteoporosis.

Authors: 马同 赵继荣 谭明远 et al.

Source: Chinese Journal of Osteoporosis. 2026, Vol. 32 Issue 2, p228-233. 6p.

Postmenopausal Osteoporosis: From Molecular Pathways to Therapeutic Targets—A Mechanism-to-Practice Framework Integrating Pharmacotherapy, Fall Prevention, and Adherence into Patient-Centered Care.

Authors: Ena, Graziella Soyfoo, Muhammad

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p102. 33p.

Postmenopausal osteoporosis increases periodontal inflammation and the pathogenicity of the oral microbiota in a rat model.

Authors: Lu, Miao Zhang, Yanan Zhang, Yang et al.

Source: Journal of Oral Microbiology. Dec2025, Vol. 17 Issue 1, p1-13. 13p.

Clinical correlation between intestinal flora profiles and the incidence of postmenopausal osteoporosis.

Authors: Zhu, Cuifeng Zhang, Yuan Pan, Yi et al.

Source: Gynecological Endocrinology. Dec2025, Vol. 41 Issue 1, p1-8. 8p.

SLIT3 蛋白与绝经后骨质疏松症相关性及诊断意义.

Alternate Title: Association between SLIT3 and postmenopausal osteoporosis and its diagnostic significance.

Authors: 刘树华 曾韵杰 杨东升 et al.

Source: Chinese Journal of Osteoporosis. 2025, Vol. 31 Issue 11, p1561-1567. 7p.

西南地区绝经后女性体力活动与膳食模式对骨质疏松症的关联研究--基于成都市郇都区的横断面调查

Alternate Title: The association between physical activity, dietary patterns, and osteoporosis in postmenopausal women in Southwest China: a cross - sectional survey based on Pidu District, Chengdu.

Authors: 邓艳萍 李东梅 刘晓燕 et al.

Source: Modern Preventive Medicine. 2025, Vol. 52 Issue 20, p3649-3661. 8p.

Research Trends in Immunomodulatory Therapy for Postmenopausal Osteoporosis: A Bibliometric Analysis.

Authors: Yi, Shenghui Liu, Janguo Chen, Huiming et al.

Source: Orthopaedic Surgery. Oct2025, Vol. 17 Issue 10, p2809-2822. 14p.

Zingerone treats postmenopausal osteoporosis via increased ferroptosis sensitivity by p53-mediated regulation of SAT1 and GPX4 expression.

Authors: Li, Hao Cao, Fangming Liu, Dian et al.

Source: Communications Biology. 9/26/2025, Vol. 8 Issue 1, p1-17. 17p.

Correlation of serum pentraxin 3 expression with disease severity and its prognostic value in postmenopausal osteoporosis.

Authors: Zhang, Bi Xiao, Jie Xin, Zengfeng et al.

Source: BMC Musculoskeletal Disorders. 9/1/2025, Vol. 26 Issue 1, p1-10. 10p.

РАННА МЕНОПАУЗА И ГЕНЕТИЧНИ ФАКТОРИ КАТО ПРЕДИКТОРИ ЗА ОСТЕО)ПОРОЗА ПРИ ЖЕНИ ОТ БЪЛГАРСКИ И РОМСКИ ПРОИЗХОД.

Alternate Title: EARLY MENOPAUSE AND GENETIC FACTORS AS PREDICTORS OF OSTEOPOROSIS IN WOMEN OF BULGARIAN AND ROMA ORIGIN.

Authors: Букова, Веселина Тодорова, Мариета Танева, Даниела et al.

Source: Management & Education / Upravlenie i Obrazovanie. 2025, Vol. 21 Issue 5, p16-22. 7p.

绝经后骨质疏松症与控制性营养状况评分及系统性免疫炎症指数的关系.

Alternate Title: Association of the controlling nutritional status score and systemic immune-inflammation index with postmenopausal osteoporosis.

Authors: 陈小晴 宫云昭 陈 巍

Source: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 8/28/2025, Vol. 29 Issue 24, p5071-5078. 8p.

雌激素缺乏导致女性骨质疏松的研究进展.

Alternate Title: Research progress of female osteoporosis caused by estrogen deficiency.

Authors: 向小蝶 李聪

Source: Journal of Modern Medicine & Health. 8/25/2025, Vol. 41 Issue 8, p1946-1949. 4p.

Bioinformatics analysis of Rho-signal transduction genes in postmenopausal osteoporosis and periodontitis.

Authors: Qi, Jing Liu, E. Pang, Yunqing et al.

Source: Scientific Reports. 8/5/2025, Vol. 15 Issue 1, p1-15. 15p.

左归丸经 ERK/ETS1/PPARy 信号通路促进 MC3T3-E1 细胞增殖与成骨分化.

Alternate Title: Zuo Gui Wan promotes proliferation and osteogenic differentiation of MC3T3-E1 cells through ERK/ETS1/PPARγ signaling pathway.

Authors: 顾金光 董永丽 李辰华 et al.

Source: Chinese Journal of Osteoporosis. 2025, Vol. 31 Issue 8, p1142-1151. 10p.

miR-370-3p affects the progression of postmenopausal osteoporosis through targeting INO80.

Authors: Yang, Zhen Sheng, Yuqi Liu, Xiangjie et al.

Source: Hereditas. 7/22/2025, Vol. 162 Issue 1, p1-11. 11p.

LncRNA SDCBP2-AS1 is a putative biomarker for postmenopausal osteoporosis and promotes osteogenic differentiation of BMSCs by regulating miR-361-3p.

Authors: Chen, Jindong Zhang, Shilong Cai, Dixin et al.

Source: Hereditas. 7/10/2025, Vol. 162 Issue 1, p1-10. 10p.